93 related articles for article (PubMed ID: 24304821)
21. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
Collazos J; Asensi V; Cartón JA
AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
[TBL] [Abstract][Full Text] [Related]
22. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
23. [Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].
Caro-Murillo AM; Castilla J; Pérez-Hoyos S; Miró JM; Podzamczer D; Rubio R; Riera M; Viciana P; López Aldeguer J; Iribarren JA; de los Santos-Gil I; Gómez-Sirvent JL; Berenguer J; Gutiérrez F; Saumoy M; Segura F; Soriano V; Peña A; Pulido F; Oteo JA; Leal M; Casabona J; del Amo J; Moreno S;
Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):23-31. PubMed ID: 17261243
[TBL] [Abstract][Full Text] [Related]
24. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
25. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
26. Risk factors associated with older age in treatment-naive HIV-positive patients.
Reuter S; Oette M; Kaiser R; Lengauer T; Fätkenheuer G; Rockstroh JK; Knechten H; Häussinger D
Intervirology; 2012; 55(2):147-53. PubMed ID: 22286885
[TBL] [Abstract][Full Text] [Related]
27. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
[TBL] [Abstract][Full Text] [Related]
28. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
[TBL] [Abstract][Full Text] [Related]
29. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
Gutiérrez F; García L; Padilla S; Alvarez D; Moreno S; Navarro G; Gómez-Sirvent J; Vidal F; Asensi V; Masiá M;
HIV Med; 2014 Apr; 15(4):213-23. PubMed ID: 24215356
[TBL] [Abstract][Full Text] [Related]
30. Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort.
Torrecilla García E; Yebra Sanz G; Llácer-Delicado T; Rubio García R; González-García J; García García F; López-Aldeguer J; Asensi Álvarez V; Holguín Fernández Á;
Enferm Infecc Microbiol Clin; 2016; 34(6):353-60. PubMed ID: 26364856
[TBL] [Abstract][Full Text] [Related]
31. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
[TBL] [Abstract][Full Text] [Related]
32. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care.
Sobrino-Vegas P; Rodríguez-Urrego J; Berenguer J; Caro-Murillo AM; Blanco JR; Viciana P; Moreno S; Bernardino I; del Amo J;
Antivir Ther; 2012; 17(1):1-8. PubMed ID: 22267463
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
[TBL] [Abstract][Full Text] [Related]
34. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
Kesselring AM; Wit FW; Sabin CA; Lundgren JD; Gill MJ; Gatell JM; Rauch A; Montaner JS; de Wolf F; Reiss P; Mocroft A;
AIDS; 2009 Aug; 23(13):1689-99. PubMed ID: 19487907
[TBL] [Abstract][Full Text] [Related]
36. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.
Mosha F; Muchunguzi V; Matee M; Sangeda RZ; Vercauteren J; Nsubuga P; Lyamuya E; Vandamme AM
BMC Public Health; 2013 Jan; 13():38. PubMed ID: 23320567
[TBL] [Abstract][Full Text] [Related]
37. [HIV infection in different age groups: Potential implications for prevention. CoRIS Cohort, Spain, 2004-2008].
Caro-Murillo AM; Gil Luciano A; Navarro Rubio G; Leal Noval M; Blanco Ramos JR;
Med Clin (Barc); 2010 Apr; 134(12):521-7. PubMed ID: 20207371
[TBL] [Abstract][Full Text] [Related]
38. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).
May MT; Ingle SM; Costagliola D; Justice AC; de Wolf F; Cavassini M; D'Arminio Monforte A; Casabona J; Hogg RS; Mocroft A; Lampe FC; Dabis F; Fätkenheuer G; Sterling TR; del Amo J; Gill MJ; Crane HM; Saag MS; Guest J; Brodt HR; Sterne JA;
Int J Epidemiol; 2014 Jun; 43(3):691-702. PubMed ID: 23599235
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in the treatment of HIV infection.
Floridia M; Giuliano M; Palmisano L; Vella S
Pharmacol Res; 2008; 58(3-4):173-82. PubMed ID: 18708144
[TBL] [Abstract][Full Text] [Related]
40. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.
Martínez-Sanz J; Blanco JR; Muriel A; Pérez-Elías MJ; Rubio-Martín R; Berenguer J; Peraire J; Bernal E; Martínez OJ; Serrano-Villar S; Moreno S;
J Int AIDS Soc; 2021 May; 24(5):e25732. PubMed ID: 34036745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
